Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review

Leuk Res. 2011 Dec;35(12):1571-7. doi: 10.1016/j.leukres.2011.06.023. Epub 2011 Jul 12.

Abstract

Plasmablastic lymphoma (PBL) is a rare aggressive B-cell lymphoproliferative disorder. HIV-negative PBL has not been extensively reported. Nine HIV-negative PBL patients evaluated at Moffitt Cancer Center were studied. Eight patients had extranodal diseases. All patients were treated with CHOP or hyper-CVAD. Responses were observed in 8 cases (7 complete, 1 partial responses). Four patients underwent consolidation with autologous hematopoietic stem cell transplant (HSCT) in first complete remission (CR1). At median follow-up of 23.9 months, 7 patients were alive and 5 were disease-free. Aggressive induction chemotherapy and consolidation with autologous HSCT in CR1 might be considered for patients with HIV-negative PBL.

Publication types

  • Evaluation Study
  • Review

MeSH terms

  • Aged
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • HIV Infections / epidemiology
  • Humans
  • Immunophenotyping
  • Lymphoma, B-Cell / epidemiology
  • Lymphoma, B-Cell / therapy*
  • Male
  • Middle Aged
  • Remission Induction
  • Retrospective Studies
  • Treatment Outcome